My NCBI | Sign In
RSS Settings
  • Search: SEEFF LB[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 133

    1.

    Diagnosis, management, and treatment of hepatitis C: an update.

    Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases.

    Hepatology. 2009 Apr;49(4):1335-74. No abstract available. PMID: 19330875 [PubMed - indexed for MEDLINE]Related articles

    2.

    The history of the "natural history" of hepatitis C (1968-2009).

    Seeff LB.

    Liver Int. 2009 Jan;29 Suppl 1:89-99. Review.PMID: 19207971 [PubMed - indexed for MEDLINE]Related articles

    3.

    Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases.

    Brinker AD, Wassel RT, Lyndly J, Serrano J, Avigan M, Lee WM, Seeff LB.

    Hepatology. 2009 Jan;49(1):250-7.PMID: 19085949 [PubMed - indexed for MEDLINE]Related articles

    4.

    Are herbals as safe as their advocates believe?

    Seeff LB.

    J Hepatol. 2009 Jan;50(1):13-6. Epub 2008 Nov 6. No abstract available. PMID: 19017552 [PubMed - indexed for MEDLINE]Related articles

    5.

    Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

    Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

    Gastroenterology. 2009 Jan;136(1):138-48. Epub 2008 Sep 18.PMID: 18848939 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.

    Rochon J, Protiva P, Seeff LB, Fontana RJ, Liangpunsakul S, Watkins PB, Davern T, McHutchison JG; Drug-Induced Liver Injury Network (DILIN).

    Hepatology. 2008 Oct;48(4):1175-83.PMID: 18798340 [PubMed - indexed for MEDLINE]Related articles

    7.

    The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.

    Mosley JW, Operskalski EA, Tobler LH, Buskell ZJ, Andrews WW, Phelps B, Dockter J, Giachetti C, Seeff LB, Busch MP; Transfusion-transmitted Viruses Study and Retrovirus Epidemiology Donor Study Groups.

    J Viral Hepat. 2008 Feb;15(2):120-8.PMID: 18184195 [PubMed - indexed for MEDLINE]Related articles

    8.

    Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

    Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group.

    Hepatology. 2008 Feb;47(2):605-12.PMID: 18157835 [PubMed - indexed for MEDLINE]Related articles

    9.

    Herbal hepatotoxicity.

    Seeff LB.

    Clin Liver Dis. 2007 Aug;11(3):577-96, vii. Review.PMID: 17723921 [PubMed - indexed for MEDLINE]Related articles

    10.

    Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a review.

    Modi AA, Wright EC, Seeff LB.

    Antivir Ther. 2007;12(3):285-95. Review.PMID: 17591018 [PubMed - indexed for MEDLINE]Related articles

    11.

    Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.

    Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB; A2ALL Study Group.

    Liver Transpl. 2007 Jan;13(1):122-9.PMID: 17192908 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Peginterferon and ribavirin for chronic hepatitis C.

    Hoofnagle JH, Seeff LB.

    N Engl J Med. 2006 Dec 7;355(23):2444-51. Review. No abstract available. PMID: 17151366 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

    Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C; HALT-C Trial Group.

    Hepatology. 2006 Dec;44(6):1675-84.PMID: 17133499 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efforts to define the natural history of chronic hepatitis C continue.

    Ghany MG, Seeff LB.

    Clin Gastroenterol Hepatol. 2006 Oct;4(10):1190-2. No abstract available. PMID: 17045209 [PubMed - indexed for MEDLINE]Related articles

    15.

    Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.

    Seeff LB, Hoofnagle JH.

    Oncogene. 2006 Jun 26;25(27):3771-7. Review.PMID: 16799618 [PubMed - indexed for MEDLINE]Related articles

    16.

    A framework for management of hepatitis C in prisons.

    Spaulding AC, Weinbaum CM, Lau DT, Sterling R, Seeff LB, Margolis HS, Hoofnagle JH.

    Ann Intern Med. 2006 May 16;144(10):762-9. Review.PMID: 16702592 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Strategies for assessing the long-term consequences of Hepatitis C virus infection.

    Seeff LB.

    Minerva Gastroenterol Dietol. 2000 Dec;46(4):207-16.PMID: 16501439 [PubMed]Related articles

    18.

    Drug-induced liver injury: summary of a single topic clinical research conference.

    Watkins PB, Seeff LB.

    Hepatology. 2006 Mar;43(3):618-31.PMID: 16496329 [PubMed - indexed for MEDLINE]Related articles

    19.

    Viral load as a predictor of progression of chronic hepatitis C?

    Heller T, Seeff LB.

    Hepatology. 2005 Dec;42(6):1261-3. No abstract available. PMID: 16317702 [PubMed - indexed for MEDLINE]Related articles

    20.

    Is cirrhosis an inevitable consequence of chronic hepatitis C virus infection?

    Seeff LB, Everhart JE.

    Clin Gastroenterol Hepatol. 2005 Sep;3(9):840-2. No abstract available. PMID: 16234019 [PubMed - indexed for MEDLINE]Related articles

    21.

    More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug use.

    Yeh MM, Buskell ZJ, Seeff LB, Strader D, Wright EC, Goodman ZD.

    J Clin Gastroenterol. 2005 Sep;39(8):722-7.PMID: 16082284 [PubMed - indexed for MEDLINE]Related articles

    22.

    Natural history of hepatitis C.

    Thomas DL, Seeff LB.

    Clin Liver Dis. 2005 Aug;9(3):383-98, vi. Review.PMID: 16023972 [PubMed - indexed for MEDLINE]Related articles

    23.

    The natural history of chronic hepatitis C virus infection.

    Seeff LB.

    Clin Liver Dis. 1997 Nov;1(3):587-602. Review.PMID: 15560060 [PubMed - indexed for MEDLINE]Related articles

    24.

    Testing for hepatitis C virus infection should be routine for persons at increased risk for infection.

    Alter MJ, Seeff LB, Bacon BR, Thomas DL, Rigsby MO, Di Bisceglie AM.

    Ann Intern Med. 2004 Nov 2;141(9):715-7. Review.PMID: 15520428 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Introduction: The burden of hepatocellular carcinoma.

    Seeff LB.

    Gastroenterology. 2004 Nov;127(5 Suppl 1):S1-4. No abstract available. PMID: 15508071 [PubMed - indexed for MEDLINE]Related articles

    26.

    Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion.

    Laskus T, Wilkinson J, Gallegos-Orozco JF, Radkowski M, Adair DM, Nowicki M, Operskalski E, Buskell Z, Seeff LB, Vargas H, Rakela J.

    Gastroenterology. 2004 Sep;127(3):764-76.PMID: 15362033 [PubMed - indexed for MEDLINE]Related articles

    27.

    Hepatitis C infection and injection drug use: the role of hepatologists in evolving treatment efforts.

    Kresina TF, Seeff LB, Francis H.

    Hepatology. 2004 Sep;40(3):516-9.PMID: 15349886 [PubMed - indexed for MEDLINE]Related articles

    28.

    Diagnosis, management, and treatment of hepatitis C.

    Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases.

    Hepatology. 2004 Apr;39(4):1147-71. No abstract available. Erratum in: Hepatology. 2004 Jul;40(1):269. PMID: 15057920 [PubMed - indexed for MEDLINE]Related articles

    29.

    Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans.

    Rao MN, Marmillot P, Gong M, Palmer DA, Seeff LB, Strader DB, Lakshman MR.

    Metabolism. 2003 Oct;52(10):1287-94.PMID: 14564680 [PubMed - indexed for MEDLINE]Related articles

    30.

    Hepatitis C and renal disease: an update.

    Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH.

    Am J Kidney Dis. 2003 Oct;42(4):631-57. Review.PMID: 14520615 [PubMed - indexed for MEDLINE]Related articles

    31.

    Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

    Seeff LB, Hoofnagle JH.

    Clin Liver Dis. 2003 Feb;7(1):261-87. Review.PMID: 12691470 [PubMed - indexed for MEDLINE]Related articles

    32.

    Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.

    Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB.

    Clin Chem. 2003 Mar;49(3):479-86.PMID: 12600961 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Natural history of chronic hepatitis C.

    Seeff LB.

    Hepatology. 2002 Nov;36(5 Suppl 1):S35-46. Review.PMID: 12407575 [PubMed - indexed for MEDLINE]Related articles

    34.

    National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.

    Seeff LB, Hoofnagle JH.

    Hepatology. 2002 Nov;36(5 Suppl 1):S1-2. No abstract available. PMID: 12407571 [PubMed - indexed for MEDLINE]Related articles

    35.

    Use of complementary and alternative medicine in patients with liver disease.

    Strader DB, Bacon BR, Lindsay KL, La Brecque DR, Morgan T, Wright EC, Allen J, Khokar MF, Hoofnagle JH, Seeff LB.

    Am J Gastroenterol. 2002 Sep;97(9):2391-7.PMID: 12358262 [PubMed - indexed for MEDLINE]Related articles

    36.

    Complementary and alternative medicine in chronic liver disease.

    Seeff LB, Lindsay KL, Bacon BR, Kresina TF, Hoofnagle JH.

    Hepatology. 2001 Sep;34(3):595-603. Review. No abstract available. PMID: 11526548 [PubMed - indexed for MEDLINE]Related articles

    37.

    Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: divergence over time.

    Lin HJ, Seeff LB, Barbosa L, Hollinger FB.

    Hepatology. 2001 Aug;34(2):424-9.PMID: 11481629 [PubMed - indexed for MEDLINE]Related articles

    38.

    Hepatitis C: a brief clinical overview.

    Strader DB, Seeff LB.

    ILAR J. 2001;42(2):107-16. Review.PMID: 11406713 [PubMed - indexed for MEDLINE]Related articles

    39.

    Prevalence and incidence of hepatitis C virus infection in the US military: a seroepidemiologic survey of 21,000 troops.

    Hyams KC, Riddle J, Rubertone M, Trump D, Alter MJ, Cruess DF, Han X, Nainam OV, Seeff LB, Mazzuchi JF, Bailey S.

    Am J Epidemiol. 2001 Apr 15;153(8):764-70.PMID: 11296148 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse.

    Harris DR, Gonin R, Alter HJ, Wright EC, Buskell ZJ, Hollinger FB, Seeff LB; National Heart, Lung, and Blood Institute Study Group.

    Ann Intern Med. 2001 Jan 16;134(2):120-4.PMID: 11177315 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.

    Seeff LB, Hollinger FB, Alter HJ, Wright EC, Cain CM, Buskell ZJ, Ishak KG, Iber FL, Toro D, Samanta A, Koretz RL, Perrillo RP, Goodman ZD, Knodell RG, Gitnick G, Morgan TR, Schiff ER, Lasky S, Stevens C, Vlahcevic RZ, Weinshel E, Tanwandee T, Lin HJ, Barbosa L.

    Hepatology. 2001 Feb;33(2):455-63.PMID: 11172349 [PubMed - indexed for MEDLINE]Related articles

    42.

    Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

    Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB.

    Clin Chem. 2000 Dec;46(12):2050-68. Review.PMID: 11106350 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.

    Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB.

    Clin Chem. 2000 Dec;46(12):2027-49. Review.PMID: 11106349 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function.

    Rao MN, Liu QH, Marmillot P, Seeff LB, Strader DB, Lakshman MR.

    Metabolism. 2000 Nov;49(11):1406-10.PMID: 11092502 [PubMed - indexed for MEDLINE]Related articles

    45.

    Why is there such difficulty in defining the natural history of hepatitis C?

    Seeff LB.

    Transfusion. 2000 Oct;40(10):1161-4. Review. No abstract available. PMID: 11061849 [PubMed - indexed for MEDLINE]Related articles

    46.

    More on viral hepatitis.

    Dufour DR, Ashwood ER, Nolte FS, Seeff LB.

    Am J Clin Pathol. 2000 Oct;114(4):660-4. No abstract available. PMID: 11026110 [PubMed - indexed for MEDLINE]Related articles

    47.

    Afterword: HCV in the decades ahead.

    Branch AD, Seeff LB.

    Semin Liver Dis. 2000;20(2):233-7. No abstract available. PMID: 10946427 [PubMed - indexed for MEDLINE]Related articles

    48.

    Liver Disease: Diagnosis and Management.

    Seeff LB.

    Ann Intern Med. 2000 Aug 15;133(4):316. No abstract available. PMID: 10929190 [PubMed - as supplied by publisher]Related articlesFree article

    49.

    Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.

    Alter HJ, Seeff LB.

    Semin Liver Dis. 2000;20(1):17-35. Review.PMID: 10895429 [PubMed - indexed for MEDLINE]Related articles

    50.

    Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus.

    Sulkowski MS, Mast EE, Seeff LB, Thomas DL.

    Clin Infect Dis. 2000 Apr;30 Suppl 1:S77-84. Review.PMID: 10770916 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity